invasion in chickens challenged with 108 CFU of highly invasive S. typhimurium or S. enteritidis strains suggests that vaccination of chickens with X3985 can complement the present hygiene-and sanitation-based Salmonella control measures. This paper reports a breakthrough in the use of live avirulent vaccine to control Salmonella carriers in chickens.
Food-borne enteric human pathogens continue to plague society on a worldwide scale and appear to be increasing despite research and management efforts to remedy the problem. In the United States, 80 to 90% of human Salmonella infections result from Salmonella transmission by persistent infection of farm animals and subsequent contamination of meat, eggs, and dairy products. In 1989, Salmonella typhimurium, S. enteritidis, S. heidelberg, S. hadar, and S. agona accounted for 57.9% of Salmonella serotypes isolated from human infections and accounted for 46.5% of isolations obtained from poultry (7) . S. enteritidis isolates in the United States belong primarily to phage types PT8 and PT13A, with 48% of poultry and 64% of animal Salmonella isolates in the United States being PT8 (23) .
The major obstacle to Salmonella control in the poultry industry is the ubiquitous presence of salmonellae. Once salmonellae get onto a farm, they spread rapidly because infected chickens and rodents serve as carriers. Salmonella carriers constantly shed salmonellae and contaminate the feeding and watering systems and the poultry farm environment. The present methods of controlling food poisoningrelated salmonellae on the farm are inadequate or too expensive to enforce. The use of antibiotics has been reduced because of complications resulting from the development of antibiotic-resistant Salmonella strains (2, 18, 30) , experimental implication of some antibiotics in enhancing Salmonella excretion (5), and the risk of feeding consumers with poultry products containing antibiotic residues. Inoculation of nonpathogenic gut flora from adult chickens into day-old chicks, a phenomenon known as competitive exclusion, has been shown to reduce colonization of young chicks by pathogenic organisms (27) . Treatment of finished poultry products with irradiation is an emerging approach but is an expensive means of product sterilization.
The emergence of S. enteritidis infection of humans as a result of egg contamination by salmonellae led to the establishment in 1990 of a task force in the United States for S. enteritidis control in the poultry industry (35) . Poultry feed is a major source of Salmonella infections for chickens, as a result of the use of Salmonella-contaminated raw materials from rendering plants. In the United States, the Food and Drug Administration Center for Veterinary Medicine has now focused on using microbiological and chemical standards instead of the old organoleptic criteria utilized in the inspection of rendering plants (24) . The ultimate aim is to obtain Salmonella-free feed. The attainment of low levels of salmonellae in feed and strict adherence to sanitary regulation and biosecurity on farms will definitely reduce the load of salmonellae on the farm. These efforts will not lead to Salmonella-free chickens because the prolific nature of salmonellae in infected chickens will obliterate all control efforts if the chickens are unable to prevent Salmonella proliferation.
Therefore, there is a need for the induction of an inherent protective mechanism within chickens at the production level that will ensure a low level or elimination of Salmonella contamination. We believe that vaccination should be a major component of a Salmonella control program. Vaccination was used to control S. gallinarum (29) , while S. pullorum was eliminated (3, 11, 12, 34) . Parenteral vaccination of chickens with outer membrane proteins of S. enteritidis was better than vaccination with killed bacteria in preventing colonization of immunized chickens by wild-type S. enteritidis after challenge (25) . Oral vaccination with live homologous salmonellae has been shown to induce protection against visceral invasion by challenge strains, with reduction in the colonization of the gastrointestinal tract (3, 20, 26, 32) . Intramuscular vaccination failed to protect vaccinated chickens against intestinal colonization (3) . (15) . This negative attribute of S. typhimurium X3761 was overcome by the deletion of the cya and crp genes from X3761 (15) . The derived Acya Acrp S. typhimurium strain, x3985, is avirulent and immunogenic (10, 14) . Immunization of chickens with x3985 induced an effective protection against challenge with highly virulent S. typhimurium X3761 (10, 14, 17 (ii) Oral vaccination at 2 and 4 weeks of age. Five groups of 10 specific-pathogen-free chickens were vaccinated at 2 weeks of age with 108 CFU of Acya Acrp S. typhimurium x3985 and boosted with the same dose at 4 weeks of age. When 6 weeks old, the vaccinated chickens and five groups of 10 nonvaccinated 6-week-old chickens were challenged with 106 CFU of S. typhimunium F98, S. infantis, S. enteritidis 27A PT8, S. enteritidis 4973 PT13A, or S. anatum. All the chickens were necropsied at 8 weeks of age.
Effect of vaccination on challenge with highly invasive Sabnonella strains. One hundred 2-week-old chickens were vaccinated orally with 108 CFU of Acya Acrp S. typhimurium x3985 and boosted with the same dose when 4 weeks of age.
The vaccinated chickens were divided into five groups of 10 chickens and challenged orally, along with five groups of 10 nonvaccinated chickens, at 6 weeks of age with 108 CFU of highly invasive S. typhimunium 2921-1 and S. enteritidis 4973 PT13A, B6996 PT13A, Y-8P2 PT8, and 27A PT8. We used 108 CFU of highly invasive Salmonella strains in order to test the limit of the protection induced by oral vaccination with x3985 against visceral invasion by heterologous wild-type Salmonella strains. Five chickens from each group were necropsied at 4 days after challenge, and five were necropsied at 11 days after challenge. All vaccination and challenge experiments were repeated.
Sample collection and processing. Chickens were euthanized by CO2 asphyxiation within 2 weeks after challenge with wild-type Salmonella strains. During necropsy, the chickens were laid on their backs with legs drawn away from the body. The skin was incised between the legs midway between the sternum and cloaca. The cut edge was forcibly reflected anteriorly to expose the ventral aspect of the body up to the neck region. The abdominal muscles and rib cage were cut from both sides anteriorly up to the clavicle, a bone shear was used to cut the clavicle, and the rib cage was reflected to one side to expose the organs in the abdominal and thoracic cavities. All samples were collected under strict aseptic conditions as described previously (15) . All samples were collected into a sterile preweighed disposable polypropylene culture tubes with a snap cap and kept on ice after sample collection. nated chickens were spleen, ovary, and bursa of Fabricius. Contents from the ileum and cecum as well as feces were also collected. All samples were homogenized as 1:10 dilutions in BSG. The samples were analyzed by decimal dilutions in BSG. The diluted samples were plated in drops on SalmonellaShigella agar and incubated at 37°C for 24 h (permitting detection of 102 CFU of salmonellae per g of sample). The presence or absence of salmonellae at concentrations below 102 CFU/g in the sample was tested by ability or inability to detect salmonellae in samples incubated in selenite cysteine broth at 37°C for 48 h, subcultured on Salmonella-Shigella agar, and incubated for 24 h at 37°C. Samples positive by selective enrichment in selenite cysteine broth were recorded as 10 CFU, and negative samples were recorded as 0 CFU.
Statistics. Statistical significance was calculated at the 0.05 level of probability, using two-way analysis of variance.
RESULTS
Protection induced by oral vaccination at 1 and 14 days of age. Colonization or invasion by the challenge Salmonella strain was determined by quantifying the amount of salmonellae in the gastrointestinal tract or visceral organs of vaccinated and nonvaccinated chickens after challenge with wild-type strains. The degree of protection was determined by comparing data obtained from vaccinated chickens with those obtained from nonvaccinated chickens. Oral vaccination of chickens at 1 and 14 days of age with Acya Acrp S. typhimurium x3985 induced significant protection against challenge with 106 CFU of wild-type homologous Salmonella strains from group B (Fig. 1) . Solid protection was observed against visceral invasion by S. typhimurium, S. agona, and S. bredeny. Salmonellae were detected only by enrichment in the ceca of vaccinated chickens challenged with S. agona and S. typhimurium (<1 CFU/g). A low level of salmonellae was detected in the bursa of Fabricius of vaccinated chickens challenged with S. heidelberg (10 CFU/g) and in the feces and cecal contents of vaccinated chickens challenged with S. heidelberg and S. bredeny (1 to 103 CFU/g). This level is very low compared with Salmonella isolation from the visceral organs (101 to 105 CFU/g) or gastrointestinal tract (106 to 107 CFU/g) of nonvaccinated chickens challenged with the same Salmonella strains (Fig. 1) .
A lower level of protection was observed in vaccinated chickens challenged with Salmonella strains in group C compared with nonvaccinated but challenged chickens (Fig. 2) . A significant level of protection was observed against challenge with Salmonella strains of group D (Fig. 3) and group E (Fig. 4) (Fig. 5 ). Salmonellae were detected only in the ceca of vaccinated chickens challenged with S. enteritidis 4973 PT13A after selenite enrichment (Fig. 5) . The amount of salmonellae isolated from the spleen, bursa of Fabricius, feces, and ceca of vaccinated chickens challenged with S. infantis was lower than the amount isolated from nonvaccinated chickens challenged with the same group C wild type (Fig. 5) ( Fig. 6 ) and S. enteritidis 4973 PT13A (Fig. 7) , Y-8P2 PT8 (Fig.  8 ), 27A PT8 (Fig. 9) , and B6996 PT13A (Fig. 10) showed that vaccination with S. typhimunum X3985 prevented invasion and colonization of the spleen and ovary 4 days after challenge compared with invasion and colonization of nonvaccinated chickens challenged with the same Salmonella serotypes. By 11 days after challenge, salmonellae were detectable only by selenite enrichment from the bursa of Fabricius, ceca, and feces from all the vaccinated and challenged groups (0 to 10 CFU/g), compared with 5 x 104 CFU of salmonellae per g isolated from the nonvaccinated chickens challenged with similar Salmonella strains (Fig. 6 to 10 ).
DISCUSSION
The Acya Acrp S. typhimurium vaccine strain is avirulent and immunogenic and induced protective immunity against S. typhimurium when used for oral vaccination in chickens (14) and mice (9, 36) . The protection induced by x3985 is dose dependent (17) . In this study, oral vaccination of chickens at 1 and 14 days of age induced a strong protection against colonization and invasion of vaccinated chickens by homologous Salmonella strains with B-group 0 antigen. A lower level of protection was observed against cecal colonization of vaccinated chickens by heterologous Salmonella strains. The results obtained are better than those from earlier studies in which oral vaccination was used to prevent colonization of the ceca by homologous strains, using S. typhimuium F98 (3, 13, 16) or x3985 (10, 14, 17) as the vaccine strain. Double oral vaccination of chickens with Acya Acrp S. typhimurium x3985 at 2 and 4 weeks of age induced a stronger protection against Salmonella serotypes from groups B, C, D, and E used in this study. Overall, protection against serotype B is excellent, protection against serotypes D and E is very good, and protection against group C strains is marginal. x3985 also induced very good protection in vaccinated chickens against 108 CFU of highly invasive S. typhimurium and S. enteritidis strains. Most of the S. entertidis strains used in this study are highly invasive and were implicated in food poisoning outbreaks in humans that were traced to eggs, with major economic loss and public health problems (19, 21, 31, 33) . Most previous investigations involving the use of live oral Salmonella vaccine strains in chickens did not address cecal colonization or were not effective in preventing cecal colonization of vaccinated chickens by homologous Salmonella strains (1, 4, 6,  26) .
The induction of excellent protection against homologous Salmonella serotypes and significant very strong protection against heterologous Salmonella serotypes induced by double oral vaccination of chickens with live avirulent X3985 at 2 and 4 weeks of age showed that vaccination at 2 and 4 weeks of age is more effective than vaccination at 1 and 14 days of age. strong cross-protection observed against Salmonella serotypes from groups D and E. The lower level of protection against Salmonella serotypes from group C in chickens vaccinated at 2 and 4 weeks of age may be due to a unique antigen that is important in group C Salmonella pathogenesis that is lacking or not well expressed in S. typhimurium. Chickens vaccinated at 2 and 4 weeks of age and then challenged with highly invasive Salmonella strains were less protected against intestinal colonization by wild-type challenge at 4 days postchallenge compared with the observed protection 1 week later (Fig. 6 to 10 ). This may be due to time of sampling postchallenge. The reduction in protection is more prominent in chickens infected with S. typhimurium 2921-1 and S. enteritidis 4973 PT13A because they are highly invasive and more virulent than other challenge strains used. The increase in level of protection with time after vaccination (Fig. 6 to 10) shows that protection is due to specific immunity, since nonspecific immunity occurs earlier in an infection and declines with time after infection, whereas specific immune responses are induced some days after infection and improve with time after infection. The induction of effective cross-protection against other Salmonella serotypes implies that a strong level of immune response has been elicited against a common immunogenic Salmonella antigen(s). Outer bacteriaceae may play a role in the induction of cross-protection immunity.
The vaccination protocol evaluated focused on the production of broilers, which are processed as table birds at 6 weeks of age, pullets, which become layers that produce eggs for an average of 1 year after 22 weeks of age, and breeders, which produce fertile eggs. There is need to control Salmonella infection at all levels of production, but contamination of meat during processing and eggs before or after being laid are the major sources of poultry-associated Salmonella infection in humans. The exposure of chickens to salmonellae from the hatchery may prevent the use of vaccination at 2 and 4 weeks of age in broiler vaccination. There will therefore be need for the development of a comprehensive vaccination program that involves vaccination of breeders and their progeny. The vaccination schedule described in this report needs to be subjected to a field trial under normal production conditions to ascertain its practicality on the farm. This report shows that avirulent live S. typhimurium vaccine strain x3985 can be useful in the control of Salmonella carriers in chickens. We are currently investigating the duration of immunity in layers and the effect of maternal antibody on colonization of a breeder's progeny by salmonellae and vaccination of a breeder's progeny. 
